New York

Hub for Emerging Applications in Life Sciences

Building on Governor Andrew Cuomo’s innovation-driven strategy, NY HEALS is a first-ever public-private research initiative that will enable the development and commercialization of leading-edge technologies to enhance the diagnosis, treatment, prevention and cure of a variety of diseases through the introduction of effective and economically-viable healthcare innovations.

NY HEALS leverages the strength of New York’s world-class academic and research institutions with global technology leaders, as showcased by IBM, to establish a unique ecosystem that brings together scientists and engineers to develop and commercialize novel nanotechnology-enabled characterization, analysis and monitoring techniques; drug development and delivery; automation and high-throughput screening; and analytics and bioinformatics.

Advancing
together
with bold
new reseach

These leading-edge technologies will be
applied to vital areas of life sciences, including:

  • Personalized Medicine
  • Neurology
  • Pharmacology
  • Oncology
  • Infectious Disease 
  • Environmental Health and Safety
  • Access to Clinical Excellence
read more >
NY Heals

NY HEALS Partners

Albany Medical Center has made extraordinary advances in brain mapping based on  clinical experience with patients as a Level 4 epilepsy center and, through collaboration with the State’s Wadsworth Laboratory under a Department of Defense grant, have been developing brain-computer interface technology to help those immobilized by disease or trauma.

Albany College of Nanoscale Science and Engineering researchers and engineers, following discussions with Albany Medical Center scientists, have identified applications of nanotechnology to improve durability and portability of material and devices placed on the brain that could collect, process, and transmit brain signals and develop emerging nanotechnology platforms for neuro-related diagnostics and therapeutic treatment strategies. Development and manufacture of materials could occur at CNSE’s Smart System Technology and Commercialization Center of Excellence (STC) in Rochester, which offers state-of-the-art capabilities for micro electro mechanical systems (MEMS) fabrication.

The Research Foundation for SUNY is the largest, most comprehensive university-connected research foundation in the country dedicated to driving SUNY’s scope, scale and diversity as an engine of New York’s innovation economy. The  RF supports nearly $1 billion in SUNY research activity annually, providing sponsored programs administration and innovation support services to SUNY faculty performing research in life sciences and medicine; engineering and nanotechnology; physical sciences and energy; social sciences, and computer and information sciences.

The University at Albany Medical Center scientists are advancing knowledge across a broad spectrum of research in the life sciences with special emphasis on cutting-edge investigation into the structure and function of biologically active molecules. Scientific research is coalesced around core interests in RNA science and technology, neuroscience, molecular evolution of disease and molecular biology. Founded on the philosophy that scientific discovery is a multidisciplinary, collaborative and highly interactive enterprise, the Life Science Research Initiative is based on a dynamic approach to scientific discovery and education.

The Jacobs Institute based in Buffalo, drives next-generation technologies in vascular medicine and related neurological diseases through trans-disciplinary collaboration among clinicians, researchers, industry and entrepreneurs. The Institute conducts clinical research on non-evasive techniques using catheters, robotics and emerging technologies in laboratory imaging and related databases while working closely with the University of Buffalo Department of Neurosurgery.

The Buffalo Niagara Medical Campus continues to grow and create an environment that a variety of life sciences, biotech, and clean-tech companies, as well as companies that can support this research and development, seek to grow within. New technologies are being developed and patented by the BNMC institutions. This ever-changing campus environment encourages groundbreaking advancements via innovation and entrepreneurism and seeks to change the way health care, science, and energy enhance quality of life.

IBM: To enable research projects, leading doctors and scientists in this initiative will have access to advanced infrastructure such as IBM’s Watson supercomputer. Watson employs natural language capabilities, hypothesis generation, and evidence-based learning to help support medical professionals in making more informed decisions about potential diagnosis and treatment options.

Rensselaer Polytechnic Institute research focuses on identifying critical “problem sets” where expertise in cognitive and high performance computing, biotechnology, and biomedical partnerships drive discovery and innovation. Working across disciplines and sectors, powerful new tools and technologies are applied to access, aggregate, and analyze data from multiple sources and in multiple formats, in order to address challenges and opportunities across the spectrum, including infectious disease, environmental health and safety, health care, biomedicine, and neurotechnology. Rensselaer was the first university to receive the Watson system.

The Wadsworth Center, New York's public health reference laboratory, has a strong commitment to research, especially in the areas of public health genomics, bacterial drug resistance, vector-borne diseases, biomonitoring for environmental toxins, and high resolution imaging. The Center also has a well-established and internationally renowned group developing adaptive neurotechnologies, such as brain-computer interface (BCI), to restore communication and control to people who are severely paralyzed by amyotrophic lateral sclerosis (ALS), strokes, spinal cord injuries, or other devastating neuromuscular disorders.

partner logos